Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandra Narcisi

Showing results (21-30 of 186) with videos related to

Pageof 19
Sort By:
The Journal of Dermatological Treatment|August 9, 2023
Upadacitinib for the treatment of atopic dermatitis in the elderly: an Italian case series of seven patientsFrancesco Piscazzi, Luigi Gargiulo, Luciano Ibba, et al.
Dermatology Reports|July 3, 2024
Atypical facial pustular folliculitis by <i>Klebsiella pneumoniae</i>: a case reportMario Valenti, Andrea Cortese, Paola Facheris, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 30, 2025
Reply to Hagino et al.: 'Importance of Upadacitinib dose escalation prior to switch to lebrikizumab'Luigi Gargiulo, Matteo Bianco, Luciano Ibba, et al.
Dermatology and Therapy|January 8, 2023
Real-Life Effectiveness and Safety of Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: A Single-Center 16-Week StudyLuigi Gargiulo, Luciano Ibba, Andrea Cortese, et al.
Clinical Drug Investigation|May 8, 2023
Intra-Class Switch Among IL-23 Inhibitors for Plaque Psoriasis: Is It Worth It?Luigi Gargiulo, Luciano Ibba, Andrea Cortese, et al.
The Journal of Dermatological Treatment|February 22, 2023
Upadacitinib for the treatment of concomitant psoriasis and atopic dermatitis: a case seriesLuigi Gargiulo, Luciano Ibba, Giulia Pavia, et al.
Expert Opinion on Biological Therapy|March 6, 2024
Tildrakizumab: the value of a personalized and flexible approach for treating moderate-to-severe plaque psoriasis in patients with high body weight or high disease burdenPaolo Dapavo, Martina Burlando, Claudio Guarneri, et al.
The Journal of Dermatological Treatment|July 28, 2023
Safety of anti-IL-23 drugs in patients with moderate-to-severe plaque psoriasis and previous tuberculosis infection: a monocentric retrospective studyLuciano Ibba, Luigi Gargiulo, Carlo Alberto Vignoli, et al.
Occupational and Environmental Medicine|July 23, 2013
Archer dermatitis: a new case of allergic contact dermatitisAntonella Tammaro, Giorgia Cortesi, Claudia Abruzzese, et al.
The Journal of Dermatological Treatment|April 7, 2023
Real-life effectiveness and safety of dupilumab in adolescents with atopic dermatitis: a 52-week single-center retrospective studyLuigi Gargiulo, Carlo Alberto Vignoli, Luciano Ibba, et al.
Pageof 19

Showing results (21-30 of 186) with videos related to

Sort By:
Pageof 19
The Journal of Dermatological Treatment|August 9, 2023
Upadacitinib for the treatment of atopic dermatitis in the elderly: an Italian case series of seven patientsFrancesco Piscazzi, Luigi Gargiulo, Luciano Ibba, et al.
Dermatology Reports|July 3, 2024
Atypical facial pustular folliculitis by <i>Klebsiella pneumoniae</i>: a case reportMario Valenti, Andrea Cortese, Paola Facheris, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 30, 2025
Reply to Hagino et al.: 'Importance of Upadacitinib dose escalation prior to switch to lebrikizumab'Luigi Gargiulo, Matteo Bianco, Luciano Ibba, et al.
Dermatology and Therapy|January 8, 2023
Real-Life Effectiveness and Safety of Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: A Single-Center 16-Week StudyLuigi Gargiulo, Luciano Ibba, Andrea Cortese, et al.
Clinical Drug Investigation|May 8, 2023
Intra-Class Switch Among IL-23 Inhibitors for Plaque Psoriasis: Is It Worth It?Luigi Gargiulo, Luciano Ibba, Andrea Cortese, et al.
The Journal of Dermatological Treatment|February 22, 2023
Upadacitinib for the treatment of concomitant psoriasis and atopic dermatitis: a case seriesLuigi Gargiulo, Luciano Ibba, Giulia Pavia, et al.
Expert Opinion on Biological Therapy|March 6, 2024
Tildrakizumab: the value of a personalized and flexible approach for treating moderate-to-severe plaque psoriasis in patients with high body weight or high disease burdenPaolo Dapavo, Martina Burlando, Claudio Guarneri, et al.
The Journal of Dermatological Treatment|July 28, 2023
Safety of anti-IL-23 drugs in patients with moderate-to-severe plaque psoriasis and previous tuberculosis infection: a monocentric retrospective studyLuciano Ibba, Luigi Gargiulo, Carlo Alberto Vignoli, et al.
Occupational and Environmental Medicine|July 23, 2013
Archer dermatitis: a new case of allergic contact dermatitisAntonella Tammaro, Giorgia Cortesi, Claudia Abruzzese, et al.
The Journal of Dermatological Treatment|April 7, 2023
Real-life effectiveness and safety of dupilumab in adolescents with atopic dermatitis: a 52-week single-center retrospective studyLuigi Gargiulo, Carlo Alberto Vignoli, Luciano Ibba, et al.
Pageof 19